Thyroid hormone has multiple effects on the cardiovascular system. These include increased cardiac contractility ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
March 9, 2007 — Pfizer has announced that the FDA has approved Lipitor (atorvastatin calcium) Tablets to reduce the risk ...
March 08, 2007
Feb. 6, 2007 — The FDA has issued an approval letter for GlaxoSmithKline’s once-a-day anticoagulant, Arixtra ...
February 05, 2007Jan. 29, 2007 — Novadaq Technologies Inc. and Apple Inc. presented new technologies to about 100 heart surgeons Sunday ...
January 28, 2007iCardiac Technologies, Inc. and Pfizer have into a multiyear research alliance to develop and validate advanced ECG ...
January 28, 2007Jan. 25, 2007 — Research emerging this week from a Harvard researcher claims there is no evidence that statins prevent ...
January 24, 2007Jan. 19, 2007 — Daiichi Sankyo Co., Ltd. and Eli Lilly and Co. have announced completion of patient enrollment in their ...
January 18, 2007Jan 11, 2007 — FDA approval last week of Anthera’s Investigational New Drug (IND) application for its lead ...
January 10, 2007Jan. 5, 2007 — An announcement from AstraZeneca is expected soon about the company’s experimental heart drug AGI ...
January 04, 2007A review by physicians at Tulane University School of Public Health and Tropical Medicine shows that Vitamin B12 ...
January 02, 2007Heartwire cites results of a new study finding that current heart-failure performance measures, with the exception of ...
January 02, 2007Taking anti-platelet medication longer than current recommendations may lower heart attack or death risks for patients ...
December 06, 2006The FDA was notified on Dec. 2 that Pfizer will suspend a large, Phase 3 trial evaluating the investigational ...
December 05, 2006CV Therapeutics has announced it will file a new drug application to the FDA for its regadenoson agent in mid-2007 ...
December 04, 2006The Society for Cardiac Angiography and Interventions (SCAI) has extended the abstract deadline for its 30th Annual ...
December 04, 2006© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now